LON:SYNC Syncona (SYNC) Share Forecast, Price & News GBX 151 -0.20 (-0.13%) (As of 06/1/2023 ET) Add Compare Share Share Today's Range 149▼ 15550-Day Range 145▼ 161.4352-Week Range 136.02▼ 213Volume190,461 shsAverage Volume548,049 shsMarket Capitalization£1.01 billionP/E Ratio471.88Dividend Yield1.06%Price TargetN/A ProfileProfileChartCompetitorsInsider TradesHeadlinesOptions ChainProfileChartCompetitorsInsider TradesHeadlinesOptions Chain About Syncona (LON:SYNC) StockSyncona Limited is a fund specializes in investments in hedge, equity and long-term alternative investment funds across multiple asset classes. It manages private equity, debt, fixed income and alternative investments. The fund prefers to invest in healthcare and life sciences sector with focus on Cell therapy, gene therapy, biologics and small molecules. The fund invests in the public equity and fixed income markets across the globe. It targets attractive medium to long term returns by investing in leading long-only and alternative investment funds with proven managers and across multiple asset classes. The firm invests in separately managed account portfolios.Read More Receive SYNC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Syncona and its competitors with MarketBeat's FREE daily newsletter. Email Address SYNC Stock News HeadlinesMay 29, 2023 | finance.yahoo.comSYNC.L - Syncona LimitedMay 12, 2023 | msn.comChardan Capital Maintains Achilles Therapeutics Plc - ADR (ACHL) Buy RecommendationJune 1, 2023 | Edge On The Street (Ad)The $193 Billion US-China War You Don't Know AboutThey're fighting for control of lithium – a key ingredient in EVs and clean energy technology. It's arguably the most important commodity of the 21st century. China owns 80% of global supply. But the US plans to grab a massive slice of the lithium market, which is forecasted to quadruple to $193 billion by 2028, according to Fortune Business Insights.April 19, 2023 | benzinga.comOMass Therapeutics Announces New Phase of Growth with Move to New Facilities and Team Expansion to Support Portfolio ProgressApril 13, 2023 | thetimes.co.ukBiotech is in Britain’s DNA but still needs investmentApril 4, 2023 | uk.finance.yahoo.comForcefield Therapeutics signs exclusive patent and know-how license agreement with Freeline TherapeuticsApril 4, 2023 | finance.yahoo.comMosaic Therapeutics Closes $28m Series A Funding and Appoints Brian Gladsden as CEOMarch 22, 2023 | americanbankingnews.comSyncona (LON:SYNC) Hits New 1-Year Low at $141.40June 1, 2023 | Edge On The Street (Ad)Graphite versus Lithium - What Investors Should KnowOver 18 million EVs will be cruising U.S roads by 2030. And every one million EVs manufactured will require 82,000 tons of the metal graphite for their batteries. That's a total of 1,476,000 tons of graphite! Graphite is actually the largest component of EV batteries - NOT lithium. Experts warn of a massive graphite shortfall, especially since North America currently has no operating graphite mines.March 15, 2023 | benzinga.comGene therapy market size to grow by USD 4,613.9 million from 2022 to 2027; The increase in special drug designations to drive growth- TechnavioFebruary 25, 2023 | thetimes.co.ukNED Awards put talent on the agendaFebruary 14, 2023 | finance.yahoo.comBio-tech - UK Bio-Tech Companies Struggle with Sinking InvestmentFebruary 7, 2023 | thetimes.co.ukSyncona catches cold from the chill afflicting biotechFebruary 3, 2023 | yahoo.comAvado announces the FastFutures Movement with its 'Impact Report & Strategic Vision 2022'February 3, 2023 | finanznachrichten.deFastFutures & Avado: Avado announces the FastFutures Movement with its 'Impact Report & Strategic Vision 2022'December 9, 2022 | lse.co.ukSyncona portfolio firm hits 70% remission rate goal in leukaemia trialNovember 21, 2022 | seekingalpha.comRichard Francis is the new CEO and President of Teva PharmaceuticalOctober 26, 2022 | barrons.comSHAREHOLDER NOTICE: Brodsky & Smith Announces an Investigation of Applied Genetic Technologies Corporation (AGTC)October 26, 2022 | nz.finance.yahoo.comSyncona Commences Tender Offer for All Outstanding Shares of Applied Genetic Technologies CorporationOctober 24, 2022 | msn.comWall Street Set to Open Higher as Markets Look to Build on Strong Week Ahead of PMI DataOctober 24, 2022 | finance.yahoo.comSmall Eye-Focused Gene Therapy Company Applied Genetic Goes Private In $24M DealOctober 24, 2022 | msn.comUS Futures Higher, Looking to Build on Strong Week Ahead of PMI DataOctober 24, 2022 | technews.tmcnet.comAGTC Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Applied Genetic Technologies Corporation Is Fair to ShareholdersOctober 15, 2022 | msn.comMan shot to death in Desert Hot Springs; suspect in custodySeptember 1, 2022 | forbes.comInvestment Update: Wealth Manager Unveils Investment AppAugust 25, 2022 | forbes.comInvestment Update: Fund Manager Close To Losing FTSE-100 StatusAugust 18, 2022 | reuters.comSYNCS.L - Syncona Ltd | Stock Price & Latest News | ReutersSee More Headlines SYNC Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Industry, Sector and Symbol Stock ExchangeLON Industry Asset Management Sub-IndustryN/A SectorComputer and Technology Current SymbolLON:SYNC Previous SymbolLON:BACT CUSIPN/A CIKN/A Webwww.bacitltd.com Phone17168531362FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX 0.32 Trailing P/E Ratio471.88 Forward P/E RatioN/A P/E GrowthN/ANet Income£212.36 million Net Margins92.35% Pretax MarginN/A Return on Equity16.86% Return on Assets10.63% Debt Debt-to-Equity Ratio64.05 Current Ratio0.52 Quick Ratio0.53 Sales & Book Value Annual Sales£229.94 million Price / Sales4.40 Cash FlowGBX 128.57 per share Price / Cash Flow1.17 Book ValueGBX 204 per share Price / Book0.74Miscellaneous Outstanding Shares669,330,000Free FloatN/AMarket Cap£1.01 billion OptionableOptionable Beta0.21 Key ExecutivesMr. Thomas Henderson (Age 57)Co-Founder & Non-Exec. Director Dr. Martin Patrick Murphy Ph.D. (Age 55)Chief Exec. Officer Mr. John McDonald (Age 58)Co-Founder Mr. Rolf Kristian Berndtson Soderstrom ACA (Age 57)BA, Chief Financial Officer Dr. Christopher J. Hollowood Ph.D. (Age 48)CIO & Managing Partner of Syncona Investment Management Ltd. Ms. Annabel ClayHead of Investor RelationsMr. Andrew CossarGen. Counsel of Syncona Investment Management Ltd.Ms. Fenella DernieExec. OfficerMr. Edward Eliot Hodgkin DPhil (Age 60)Sr. Partner Ms. Nikki Padden Ph.D.Head of Fin. at Syncona Investment Management Ltd.More ExecutivesKey CompetitorsIdeagenLON:IDEACodemasters GroupLON:CDMGamma CommunicationsLON:GAMAAuction Technology GroupLON:ATGWANdiscoLON:WANDView All Competitors SYNC Stock - Frequently Asked Questions How have SYNC shares performed in 2023? Syncona's stock was trading at GBX 181 at the beginning of 2023. Since then, SYNC stock has decreased by 16.6% and is now trading at GBX 151. View the best growth stocks for 2023 here. What other stocks do shareholders of Syncona own? Based on aggregate information from My MarketBeat watchlists, some companies that other Syncona investors own include Rexahn Pharmaceuticals (REXN), Barrick Gold (ABX), Agnico Eagle Mines (AEM), Franco-Nevada (FNV), Goldex Resources (GDX), VanEck Gold Miners ETF (GDX), Goldcorp (GG), Barrick Gold (GOLD) and Northern Dynasty Minerals (NAK). What is Syncona's stock symbol? Syncona trades on the London Stock Exchange (LON) under the ticker symbol "SYNC." How do I buy shares of Syncona? Shares of SYNC stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What is Syncona's stock price today? One share of SYNC stock can currently be purchased for approximately GBX 151. How much money does Syncona make? Syncona (LON:SYNC) has a market capitalization of £1.01 billion and generates £229.94 million in revenue each year. The company earns £212.36 million in net income (profit) each year or GBX 0.32 on an earnings per share basis. How can I contact Syncona? Syncona's mailing address is Trafalgar Court, Les Banques, PO Box 255, ST PETER PORT, GY1 3QL, Guernsey. The official website for the company is www.bacitltd.com. The company can be reached via phone at 17168531362. This page (LON:SYNC) was last updated on 6/1/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Syncona Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.